Screener
Relay Therapeutics, Inc. RLAY Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses | 34,079 | 13,645 |
| Operating lease liabilities | 4,014 | 3,765 |
| Other current liabilities | 1,252 | 463 |
| Total current liabilities | 50,804 | 25,578 |
| Operating lease liabilities, net of current portion | 26,644 | 28,693 |
| Total liabilities | 77,448 | 54,271 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s total current liabilities?
- Relay Therapeutics, Inc. (RLAY) reported total current liabilities of $50.8M in Q2 2026.
- How has Relay Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s total current liabilities increased by 56.2% year-over-year, from $32.53M to $50.8M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total current liabilities has grown at a 13.4% compound annual growth rate (CAGR), from $13.63M to $25.58M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Relay Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude